These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 2196168)

  • 61. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiovascular effects of pinacidil and propranolol alone and in combination in normal humans.
    Nicholls DP; McNeill J; Harron DW; Shanks RG
    J Cardiovasc Pharmacol; 1986; 8(1):51-4. PubMed ID: 2419692
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacological rationale for antihypertensive drug treatment.
    Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S6-17. PubMed ID: 2454370
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.
    Piepho RW; Fendler KJ
    Drugs Aging; 1991 May; 1(3):194-211. PubMed ID: 1686570
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intravenous pinacidil in the acute treatment of hypertension.
    Rijk MC; Thien T
    J Clin Pharmacol; 1987 Jul; 27(7):468-74. PubMed ID: 3308975
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The rational use of diuretics in the treatment of arterial hypertension.
    Mroczek WJ
    Angiology; 1976 Jun; 27(6):358-69. PubMed ID: 1053479
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE; Martynyuk TV
    Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
    Brogden RN; Todd PA; Sorkin EM
    Drugs; 1988 Nov; 36(5):540-600. PubMed ID: 3063499
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term effects of pinacidil in hypertensive dialysis patients.
    Breen EG; Mulhall D; Keogh JA
    Eur J Clin Pharmacol; 1985; 28(4):375-80. PubMed ID: 4029243
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antihypertensive effects of pinacidil in patients with and without indomethacin pretreatment.
    Cinquegrani MP; Liang CS
    Clin Exp Hypertens A; 1988; 10(3):411-31. PubMed ID: 3359658
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers.
    Girard P; Saumet JL; Dubois F; Boissel JP
    Eur J Clin Pharmacol; 1993; 44(2):177-82. PubMed ID: 8453963
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide.
    Corder CN; Goldberg MR; Alaupovic PA; Price MD; Furste SS
    Eur J Clin Pharmacol; 1992; 42(1):65-70. PubMed ID: 1541318
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute hemodynamic effects of pinacidil in hypertensive patients with and without propranolol pretreatment.
    Stone CK; Wellington KL; Willick A; Sullebarger JT; Liang CS
    J Clin Pharmacol; 1991 Apr; 31(4):333-41. PubMed ID: 2037705
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis and pharmacological evaluation of N-(6-functionalized-amino-3-pyridyl)-N'-bicycloalkyl-N''-cyanoguanidine s as antihypertensive agents.
    Eda M; Takemoto T; Okada T; Sakashita H; Matzno S; Gohda M; Hayashi K; Nakamura N; Fukaya C
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):307-13. PubMed ID: 8998837
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.
    Carlsen JE; Kardel T; Hilden T; Tangø M; Trap-Jensen J
    Clin Physiol; 1981 Aug; 1(4):375-84. PubMed ID: 7199409
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vascular effects in dogs of pinacidil (P 1134), a novel vasoactive antihypertensive agent.
    Olsen UB; Arrigoni-Martelli E
    Eur J Pharmacol; 1983 Apr; 88(4):389-92. PubMed ID: 6407852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.